ATE108459T1 - Antagonisten des fibroblasten-wachstumsfaktors. - Google Patents

Antagonisten des fibroblasten-wachstumsfaktors.

Info

Publication number
ATE108459T1
ATE108459T1 AT87303489T AT87303489T ATE108459T1 AT E108459 T1 ATE108459 T1 AT E108459T1 AT 87303489 T AT87303489 T AT 87303489T AT 87303489 T AT87303489 T AT 87303489T AT E108459 T1 ATE108459 T1 AT E108459T1
Authority
AT
Austria
Prior art keywords
arg
growth factor
fibroblast growth
antagonists
fgf
Prior art date
Application number
AT87303489T
Other languages
English (en)
Inventor
Andrew Jacques Baird
Nicholas Chai-Kwan Ling
Original Assignee
Salk Inst For Biological Studi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Inst For Biological Studi filed Critical Salk Inst For Biological Studi
Application granted granted Critical
Publication of ATE108459T1 publication Critical patent/ATE108459T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT87303489T 1986-04-22 1987-04-21 Antagonisten des fibroblasten-wachstumsfaktors. ATE108459T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85484386A 1986-04-22 1986-04-22

Publications (1)

Publication Number Publication Date
ATE108459T1 true ATE108459T1 (de) 1994-07-15

Family

ID=25319659

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87303489T ATE108459T1 (de) 1986-04-22 1987-04-21 Antagonisten des fibroblasten-wachstumsfaktors.

Country Status (6)

Country Link
US (1) US5132408A (de)
EP (1) EP0246753B1 (de)
JP (1) JPS62259598A (de)
AT (1) ATE108459T1 (de)
AU (1) AU7180787A (de)
DE (1) DE3750197D1 (de)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252718A (en) * 1986-04-22 1993-10-12 The Salk Institute For Biological Studies Fibroblast growth factor antagonists
US5852177A (en) * 1987-02-24 1998-12-22 Takeda Chemical Industries, Ltd. Basic fibroblast growth factor (bFGF) muteins
US5821223A (en) * 1990-09-14 1998-10-13 The United States Of America As Represented By The Department Of Health And Human Services Method of stimulating cell growth with a novel broad spectrum human lung fibroblast-derived mitogen
AU650292B2 (en) * 1990-09-14 1994-06-16 United States of America, as represented by the Secretary, U.S. Department of Commerce, The A non-mitogenic competitive HGF antagonist
US6566098B1 (en) 1990-09-14 2003-05-20 The United States Of America As Represented By The Department Of Health And Human Services DNA encoding truncated hepatocyte growth factor variants
US5206354A (en) * 1990-11-23 1993-04-27 American Cyanamid Company Dna sequence encoding active fragment of fibroblast growth factor, hbf-2
AU1052492A (en) * 1991-01-31 1992-08-06 Farmitalia Carlo Erba S.R.L. Synergistic composition comprising a fibroblast growth factor and a sulfated polylsaccharide, for use as antiviral agent
AU1194092A (en) * 1991-02-06 1992-09-07 Georgetown University Receptor blocking peptides of fibroblast growth factor receptor
US7119182B1 (en) 1991-02-19 2006-10-10 The Regents Of The University Of California Recombinant thrombin receptor and related pharmaceuticals
US5688768A (en) * 1991-02-19 1997-11-18 Cor Therapeutics, Inc. Recombinant thrombin receptor and related pharmaceuticals
US5492894A (en) * 1991-03-21 1996-02-20 The Procter & Gamble Company Compositions for treating wrinkles comprising a peptide
EP0505108B1 (de) * 1991-03-21 1995-10-18 The Procter & Gamble Company Mittel zur Kontrolle von Hautfalten, die die Arg-Ser-Arg-Lys-Sequenzen enthalten
US5326695A (en) * 1992-05-15 1994-07-05 Ludwig Institute For Cancer Research Platelet derived growth factor agonists
US5444151A (en) * 1992-05-15 1995-08-22 Ludwig Institute For Cancer Research Platelet derived growth factor antagonists
CA2142185A1 (en) * 1992-08-10 1994-02-17 David I. Gwynne Inhibitors of cell proliferation, their preparation and use
IL108367A0 (en) * 1993-01-27 1994-04-12 Hektoen Inst For Medical Resea Antisense polynzcleotide inhibition of human growth factor-sensitive cancer cells
US5571787A (en) 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
WO1996039509A1 (en) * 1995-06-05 1996-12-12 Human Genome Sciences, Inc. Fibroblast growth factor 15
US5773252A (en) 1995-06-05 1998-06-30 Human Genome Sciences, Inc. Fibroblast growth factor 15
US6271196B1 (en) 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
US6849602B1 (en) 1996-03-05 2005-02-01 The Regents Of The University Of California Compositions for alleviating neuropathic pain with prosaposin receptor agonists
US6143723A (en) * 1996-05-20 2000-11-07 Ramaiah; Abburi Pigmentory agent
AU722626B2 (en) * 1996-05-20 2000-08-10 Abburi Ramaiah Cosmetic preparation
US6214795B1 (en) 1996-11-12 2001-04-10 Praecis Pharmaceuticals, Inc. Peptide compounds useful for modulating FGF receptor activity
EP0979238A4 (de) * 1997-03-05 2000-08-23 Univ California Methode zur heilung neuropathischer schmerzen
US6274712B1 (en) 1997-12-23 2001-08-14 3-Dimensional Pharmaceuticals, Inc. Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137
US6548634B1 (en) * 1998-09-30 2003-04-15 Chiron Corporation Synthetic peptides having FGF receptor affinity
ITRM20010088A1 (it) * 2001-02-21 2002-08-21 Idi Irccs Peptide in grado di inibire l'attivita' del fattore di crescita derivato dalle piastrine (pdgf-bb) e del fattore di crescita derivato dai fi
AU2006290251B2 (en) * 2005-09-13 2011-12-08 Abburi Ramaiah Agonist peptides of basic fibroblast growth factor (BFGF) and the method of reduction of wrinkle on skin, darkening of hair and acceleration of wound healing
JP5360738B2 (ja) * 2008-03-03 2013-12-04 国立大学法人 奈良先端科学技術大学院大学 細胞増殖促進活性を有するペプチド
JP2012518657A (ja) 2009-02-25 2012-08-16 オーエスアイ・ファーマシューティカルズ，エルエルシー 併用抗癌治療
WO2010099364A2 (en) 2009-02-27 2010-09-02 Osi Pharmaceuticals, Inc. Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
WO2010099363A1 (en) 2009-02-27 2010-09-02 Osi Pharmaceuticals, Inc. Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
WO2010099138A2 (en) 2009-02-27 2010-09-02 Osi Pharmaceuticals, Inc. Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
EP2558115B1 (de) 2010-04-16 2019-07-31 The Salk Institute for Biological Studies Verfahren zur behandlung von stoffwechselstörungen mittels fgf
CN102212568A (zh) * 2011-03-22 2011-10-12 深圳大学 用酶催化合成药物l-多巴的方法
WO2012149014A1 (en) 2011-04-25 2012-11-01 OSI Pharmaceuticals, LLC Use of emt gene signatures in cancer drug discovery, diagnostics, and treatment
TW201245221A (en) * 2011-05-02 2012-11-16 Baxter Int FGF based fibrin binding peptides
WO2013131091A1 (en) 2012-03-02 2013-09-06 New York University Chimeric fgf21 proteins with enhanced binding affinity for beta-klotho for the treatment of type ii diabetes, obesity and related metabolic disorders
WO2013152252A1 (en) 2012-04-06 2013-10-10 OSI Pharmaceuticals, LLC Combination anti-cancer therapy
US9464126B2 (en) 2012-06-07 2016-10-11 New York University Chimeric fibroblast growth factor 21 proteins and methods of use
US9474785B2 (en) 2012-06-07 2016-10-25 New York University Chimeric fibroblast growth factor 19 proteins and methods of use
US9657075B2 (en) 2012-06-07 2017-05-23 New York University Chimeric fibroblast growth factor 23 proteins and methods of use
WO2014130659A1 (en) 2013-02-22 2014-08-28 New York University Chimeric fibroblast growth factor 23 proteins and methods of use
WO2015061331A1 (en) 2013-10-21 2015-04-30 Salk Institute For Biological Studies Chimeric fibroblast growth factor (fgf) 2/fgf1 peptides and methods of use
JP6621752B2 (ja) 2013-10-21 2019-12-18 ソーク インスティテュート フォー バイオロジカル スタディーズ 変異した線維芽細胞増殖因子（ｆｇｆ）１および使用方法
CA3002400A1 (en) 2015-10-30 2017-05-04 Salk Institute For Biological Studies Treatment of steroid-induced hyperglycemia with fibroblast growth factor (fgf) 1 analogs
US11542309B2 (en) 2019-07-31 2023-01-03 Salk Institute For Biological Studies Fibroblast growth factor 1 (FGF1) mutant proteins that selectively activate FGFR1B to reduce blood glucose
CN112110988A (zh) * 2020-08-21 2020-12-22 温州医科大学 一种具有毛发生长作用的多肽类似物及制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444760A (en) * 1983-06-17 1984-04-24 Merck & Co., Inc. Purification and characterization of a protein fibroblast growth factor
EP0248819B2 (de) * 1985-09-12 2000-08-30 Scios Inc. Rekombinanter fibroblast-wachstumsfaktor

Also Published As

Publication number Publication date
JPS62259598A (ja) 1987-11-11
DE3750197D1 (de) 1994-08-18
EP0246753A3 (en) 1989-06-07
AU622708B2 (en) 1992-04-16
EP0246753A2 (de) 1987-11-25
EP0246753B1 (de) 1994-07-13
AU7180787A (en) 1987-10-29
AU4235089A (en) 1990-01-18
US5132408A (en) 1992-07-21

Similar Documents

Publication Publication Date Title
ATE108459T1 (de) Antagonisten des fibroblasten-wachstumsfaktors.
ES2147558T3 (es) Nuevos polipeptidos para promover la fijacion celular.
ATE81779T1 (de) Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.
PH20343A (en) Cysteline-depleted muteins of biologically active proteins
ATE39700T1 (de) Synthetisches hitzestabiles enterotoxinpolypeptid und dessen multimere.
PL323858A1 (en) Compounds and peptides capable to bond to a receptor of erythropoetin
DK0397633T3 (da) Fibronectinbindende protein samt fremstilling deraf
ATE372382T1 (de) Ein faktor viii-polypeptid mit faktor viii:c- aktivität
IL134982A0 (en) Antibodies which react with polypeptides of cd-44 surface proteins and diagnostic and pharmaceutical compositions prepared therewith
DE3888921T2 (de) Polypeptide.
DE3782073T2 (de) Synthetische atriale peptide.
DE69126487T2 (de) cDNA für Ratten C-Typ natriuretisches Peptid und Vorläuferprotein
KR900702027A (ko) 사람 / 소의 염기성 섬유 아세포 성장 인자의 유도체
DE69029377T2 (de) Substituierungsanaloge von magaininpeptiden
DK1612555T3 (da) Kryptiske peptider til anvendelse til at inducere immunologisk tolerance
ATE141947T1 (de) Klonierung eines neuen mitgliedes der familie der fibroblasten-wachstumsfaktoren (fgf)-rezeptoren
DK0938555T3 (da) Konstruktioner og komplekser af cyclin E
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
DK0540560T3 (da) Ancrod-lignende proteiner, fremstilling og anvendelse deraf
ATE94563T1 (de) Kristallinische polypeptide mit corticotroper aktivitaet.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties